Provided by University of Connecticut School of Medicine Office of Community and Continuing Medical Education and Orthopaedic Surgery

 

Speaker: Santiago A. Lozano-Calderon M.D, PhD

 

 

 

 

Session Attendance Code: RUMPOS

 

1.  Refresh on recent updates in myxofibrosarcoma surgical care.

2.  Expand knowledge about the limits of systemic therapy for myxofibrosarcoma.

3.  Acquire how VAC usage has changed the infection landscape for myxofibrosarcoma.

 

Speaker Disclosure Statement: Dr. Santiago Lozano-Calderon, for this educational event, has a financial relationship(s) with IlluminOss Medical, Carbofix Orthopedics, Onkos Surgical, and Bonesupport that could be perceived as a real or apparent conflict of interest in the context of their role as the speaker. The following mitigated safeguard(s) have been put into place: The activity director will restrict the speaker's presentation involvement to areas outside the area of conflict. All the relevant financial relationships listed for this individual have been mitigated.

Speaker Off-label Statement: Dr. Santiago Lozano-Calderon will not be discussing the off-label, or investigational use of any product or device. 

Target Audience: Orthopedic Surgeons, Faculty and residents, mid-levels, and physical therapists

Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Connecticut School of Medicine designates this live activity for a maximum of _ 1 _ AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Activity Directors & Planning Committee Disclosure Statement: Neither the activity directors, the activity administrator, nor the planning committee members in their role as planning committee members for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. There are no relevant financial relationships listed for these individuals to be mitigated.

Commercial Support Statement: This CME activity has no commercial support associated with it.